Studies on the effects of bone marrow stem cells on mitochondrial function and the alleviation of ARDS

[1]  M. Wujtewicz,et al.  COVID-19 – what should anaethesiologists and intensivists know about it? , 2020, Anaesthesiology intensive therapy.

[2]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[3]  A. Artigas,et al.  Current Status of Stem Cell Therapy for Sepsis and Acute Respiratory Distress Syndrome , 2019, Innovations in Cell Research and Therapy.

[4]  J. Laffey,et al.  Cell therapy in acute respiratory distress syndrome. , 2018, Journal of thoracic disease.

[5]  R. Nanchal,et al.  Recent advances in understanding and treating acute respiratory distress syndrome , 2018, F1000Research.

[6]  S. Cassel,et al.  Mitochondria in innate immune signaling. , 2018, Translational research : the journal of laboratory and clinical medicine.

[7]  A. Panariti,et al.  Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection , 2018, Front. Immunol..

[8]  K. Tarte,et al.  Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS , 2018, European Respiratory Journal.

[9]  Daniel Brodie,et al.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.

[10]  J. Laffey,et al.  Lessons to learn from epidemiologic studies in ARDS , 2017, Current opinion in critical care.

[11]  F. D’Alessio.  Mouse Models of Acute Lung Injury and ARDS. , 2018, Methods in molecular biology.

[12]  J. L. Rosa,et al.  Mesenchymal stem cells improves survival in LPS‐induced acute lung injury acting through inhibition of NETs formation , 2017, Journal of cellular physiology.

[13]  E. K. Cunningham,et al.  Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer , 2017, American journal of respiratory and critical care medicine.

[14]  S. Black,et al.  ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) , 2017, Advances in experimental medicine and biology.

[15]  Mel S. Lee,et al.  Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis , 2017, Oncotarget.

[16]  C. Xiang,et al.  Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury , 2017, International journal of molecular sciences.

[17]  Anoop Babu Vasandan,et al.  Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism , 2016, Scientific Reports.

[18]  J. Laffey,et al.  Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome , 2016, F1000Research.

[19]  D. Canale,et al.  Treatment With Human Wharton's Jelly‐Derived Mesenchymal Stem Cells Attenuates Sepsis‐Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction , 2016, Stem cells translational medicine.

[20]  Szymon Kaczanowski,et al.  Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging , 2016, Physical biology.

[21]  Edilene S. Siqueira-Santos,et al.  Underestimation of the Maximal Capacity of the Mitochondrial Electron Transport System in Oligomycin-Treated Cells , 2016, PloS one.

[22]  E. Kovacs,et al.  Alveolar macrophage inflammatory mediator expression is elevated in the setting of alcohol use disorders. , 2016, Alcohol.

[23]  Simon C Watkins,et al.  Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs , 2015, Nature Communications.

[24]  R. C. Loza,et al.  Ventilator-Induced Lung Injury (VILI) in Acute Respiratory Distress Syndrome (ARDS): Volutrauma and Molecular Effects. , 2015 .

[25]  Antonio Artigas,et al.  Management of severe sepsis: advances, challenges, and current status , 2015, Drug design, development and therapy.

[26]  B. Thompson,et al.  Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. , 2015, The Lancet. Respiratory medicine.

[27]  C. Tiruppathì,et al.  Endothelial FoxM1 Mediates Bone Marrow Progenitor Cell‐Induced Vascular Repair and Resolution of Inflammation following Inflammatory Lung Injury , 2014, Stem cells.

[28]  D. Prockop,et al.  Mesenchymal Stem/Stromal Cells Inhibit the NLRP3 Inflammasome by Decreasing Mitochondrial Reactive Oxygen Species , 2014, Stem cells.

[29]  Timothy M. Williams,et al.  Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury. , 2014, American journal of physiology. Renal physiology.

[30]  S. Reddy,et al.  Reactive oxygen species in inflammation and tissue injury. , 2014, Antioxidants & redox signaling.

[31]  K. Das.  Hyperoxia Decreases Glycolytic Capacity, Glycolytic Reserve and Oxidative Phosphorylation in MLE-12 Cells and Inhibits Complex I and II Function, but Not Complex IV in Isolated Mouse Lung Mitochondria , 2013, PloS one.

[32]  Arthur S Slutsky,et al.  Acute respiratory distress syndrome: new definition, current and future therapeutic options. , 2013, Journal of thoracic disease.

[33]  G. Martin,et al.  Stem cells in sepsis and acute lung injury. , 2010, Critical care medicine.

[34]  Yi Zhang,et al.  A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone , 2010, Nature Protocols.

[35]  A. Girbes,et al.  Pharmacological treatment of sepsis , 2008, Fundamental & clinical pharmacology.

[36]  Jae W. Lee,et al.  Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 , 2007, The Journal of Immunology.

[37]  R. Frey,et al.  Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. , 2006, The Journal of clinical investigation.

[38]  Y. Tang,et al.  Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. , 2005, Journal of the American College of Cardiology.